Fate Therapeutics (FATE) Operating Leases (2019 - 2026)
Fate Therapeutics' Operating Leases was $70.75 million in Q2 2026, down 6.5% from $75.68 million a year earlier and down 1.8% from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Operating Leases at Fate Therapeutics came in at $73.29 million, down 5.9% from FY2024.
- Operating Leases has now declined for four consecutive years, with a five-year compound annual growth rate of -4.8% (FY2020 to FY2025).
- In earlier years, Operating Leases was $77.85 million in FY2024 (-20.0%), $97.36 million in FY2023 (-6.1%), $103.71 million in FY2022 (-5.1%) and $109.24 million in FY2021 (+16.3%).
- The Q2 2026 figure marks the lowest quarterly Operating Leases since Q4 2019.
- Compared with a year earlier, Operating Leases has declined for 15 straight quarters, with an average decline of 13.0% over the last eight quarters.
- The best year-over-year quarter for Operating Leases over five years was Q3 2021 (growth of 25.5%); the worst was Q4 2024 (a decline of 20.0%).
- Per Business Quant data, FATE's Operating Leases in the three quarters before Q2 2026 was $72.05 million (Q1 2026), $73.29 million (Q4 2025) and $74.49 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Fate Therapeutics | 277.73 Mn | 277.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 70.75 Mn |
| Mar 31, 2026 | 72.05 Mn |
| Dec 31, 2025 | 73.29 Mn |
| Sep 30, 2025 | 74.49 Mn |
| Jun 30, 2025 | 75.68 Mn |
| Mar 31, 2025 | 76.79 Mn |
| Dec 31, 2024 | 77.85 Mn |
| Sep 30, 2024 | 92.09 Mn |
| Jun 30, 2024 | 93.92 Mn |
| Mar 31, 2024 | 95.67 Mn |
| Dec 31, 2023 | 97.36 Mn |
| Sep 30, 2023 | 98.98 Mn |
| Jun 30, 2023 | 100.56 Mn |
| Mar 31, 2023 | 102.07 Mn |
| Dec 31, 2022 | 103.71 Mn |
| Sep 30, 2022 | 105.16 Mn |
| Jun 30, 2022 | 106.59 Mn |
| Mar 31, 2022 | 107.94 Mn |
| Dec 31, 2021 | 109.24 Mn |
| Sep 30, 2021 | 104.36 Mn |
API Access
Fate Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();